The Business Magazine - B2B Business News - Site Logo
The Business Magazine May 2024
Read now
PICK YOUR EDITION

Surrey Research Park to host canine chemotherapy trials

2 March 2023
Share
The Business Magazine article image for: Surrey Research Park to host canine chemotherapy trials

Guildford-based AURA Veterinary has revealed their plans for clinical trials of two new canine chemotherapy techniques. The trials will take place at Surrey Research Park.

AURA are working with the University of Surrey on one of the projects, named: Development of Oncology Proxy-Reported Outcome Measure (CO-PROM).

The study, which is partially funded by the Kennel Club Charitable Trust, aims to develop similar tools to patient-reporting monitoring systems that were part of research previously conducted by The University of Surrey.

This research indicated that said systems could improve chemotherapy-related symptoms in humans, the aim is for the study with AURA to yield the same results for canine chemotherapy.

Owners of dogs that have been diagnosed with cancer and are receiving chemotherapy from AURA will be asked to complete a daily online questionnaire for a maximum of 21 days. Some will also be invited to participate in an online interview to give feedback on the questionnaire.

A second study, which is being conducted by AURA, the University of Edinburgh, and Leipzig University, is examining whether artificial sweetener aspartame can reduce the risk of dogs developing chemotherapy-induced diarrhoea.

This second study is being conducted in similar fashion to the first in the sense that it is following results from a previous focused on humans rather than dogs.

Dogs that have been diagnosed with cancer and are receiving vincristine or doxorubicin (single-agent or CHOP-based protocol) can be enrolled at any of the three sites.

The study, which has received a Purina Institute Resident Research Award from the European College of Veterinary Internal Medicine – Companion Animals Clinical Studies Fund, covers the costs of both food supplements and faecal analysis. Participants who complete all stages of the study will have the cost of their initial consultation refunded.

Read more – Oxford’s Brainomix involved in new UK atrial fibrillation study


Tom Kilkelly started working as a freelance journalist for The Business Magazine following his graduation from UCL in 2022.

During his studies Tom became very interested in the works of Irish authors including Samuel Beckett and Flann O'Brien (Brian O'Nolan).

His current role as a freelance business reporter is his first exposure to the world of business journalism. Working at TBM has given Tom the chance to really get to grips with the goings-on in the business hive that is the South East.

Related articles

Latest Deal Ticket

view more
Entropie (Buckinghamshire)
has been acquired by
Focus Group (West Sussex)
May 2024
UNDISCLOSED
Who's behind the deal?

Upcoming events

view more
06
Jun

South Coast Property Awards 2024

Hilton Southampton
Utilita Bowl
More info
12
Jun

Leadership Roundtable: Developing strategies for financial returns over the next decade

Herrington Carmichael, Farnborough Aerospace Centre, GU14 6XR

More info
18
Jul

Thames Valley Tech & Innovation Awards 2024

Reading FC Conference & Events
Select Car Leasing Stadium, Reading
More info
26
Sep

Thames Valley Property Awards 2024

Ascot Pavilion
Ascot Racecourse
More info
03
Oct

South Coast Tech & Innovation Awards 2024

Hilton Southampton
Utilita Bowl
More info
07
Nov

Thames Valley Deals Awards 2024

Reading FC Conference & Events
Select Car Leasing Stadium, Reading
More info
21
Nov

Hampshire Business Awards 2024

Farnborough International
Exhibition & Conference Centre
More info

Related articles